On the other hand, treatment with L-ca in a dose- dependent manner reduced the expression levels of caspase-9, NGAL, and KIM-1 compared to the MSG group and reversed its adverse effects
In the subgroup of patients who were obese at the beginning of the trials, the weight changes were more substantial
For example, pH-responsive nanoparticles counteract MDR by releasing drugs in the acidic tumor microenvironment, a major contributor to drug resistance in cancer cells (99, 108)
Then there were these other small molecules that didn't have safety problems associated with them, so that meant that the entire field of obesity and big pharma died out for some time
The implicit message seemed to be: Weight loss is a nicety, not a medical condition linked to type 2 diabetes, heart disease, high blood pressure, stroke, a host of cancers, anxiety, depression, and polycystic ovary syndrome, to name a few